|
INTERNATIONAL JOURNAL OF SCIENTIFIC DEVELOPMENT AND RESEARCH International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2455-2631 | Impact factor: 8.15 | ESTD Year: 2016 open access , Peer-reviewed, and Refereed Journals, Impact factor 8.15 |
Imp Links for Author
Imp Links for Reviewer
Research Area
Subscribe IJSDR
Visitor Counter
Copyright Infringement Claims
Indexing Partner
|
Published Paper Details
|
|
| Paper Title: | Pharmacovigilance: A Cross-Sectional Hospital Base Research Survey on Antihypertensive Drugs and their Adverse Drug Reaction |
| Authors Name: | Tushar Bhatkar , Purvesh Kewati , Prajwal Niwal , Preet Zatale , Pramod Burakale |
| Unique Id: | IJSDR2402038 |
| Published In: | Volume 9 Issue 2, February-2024 |
| Abstract: | Aim: The study's goals were to identify and document adverse drug reactions (ADRs) in adult male and female patients as well as elderly patients receiving antihypertensive medication treatment at the Super Speciality Hospital in Amravati. Methods: Using in-patients at a Super Speciality Hospital, we conducted a three-month survey-based cross-sectional study. Patients were included based on predetermined criteria, and GraphPad Prism and Microsoft Excel 7 were used for data analysis. Results: The study highlights how important it is to use drug usage and prescription pattern surveys to comprehend how medications affect society. It shows that during combination therapy for antihypertensive agents, there is a greater incidence of essential hypertension in men and a rise in adverse drug reactions (ADRs), particularly in women, such as sweating and weakness. Commonly administered antihypertensive telmisartan exhibits notable adverse drug reactions (ADRs), underscoring the need for customised treatment regimens and close observation in addition to blood pressure management. All things considered, the results offer insightful information for tailored treatment, illuminating the intricate dynamics of drug use and its effects. Conclusion: To sum up, telmisartan has become the most often prescribed angiotensin II receptor blocker (ARB) within its respective category. Adverse drug reactions (ADRs) were notably more common in females, with frequent reports of headache, nausea, weakness, sweating, and dizziness. After analysing the demographic information, co-morbidities, use of ARBs, and the variety of ADRs linked to different ARBs in research participants, it was evident that improving ADR management and preventive measures can greatly improve treatment outcomes for patients. |
| Keywords: | Calcium Channel Blockers, Amlodipine, Metoprolol (Beta Blockers), Telmisartan-40 Mg, Angiotensin Receptor Blockers (ARBS), Antihypertensive Medications. |
| Cite Article: | "Pharmacovigilance: A Cross-Sectional Hospital Base Research Survey on Antihypertensive Drugs and their Adverse Drug Reaction", International Journal of Science & Engineering Development Research (www.ijsdr.org), ISSN:2455-2631, Vol.9, Issue 2, page no.265 - 270, February-2024, Available :http://www.ijsdr.org/papers/IJSDR2402038.pdf |
| Downloads: | 000338719 |
| Publication Details: | Published Paper ID: IJSDR2402038 Registration ID:210081 Published In: Volume 9 Issue 2, February-2024 DOI (Digital Object Identifier): Page No: 265 - 270 Publisher: IJSDR | www.ijsdr.org ISSN Number: 2455-2631 |
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijsdr.org
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | DOAJ : Directory of Open Access Journals |
| DRJI | Index Copernicus International | Scribd | DocStoc |
Track Paper
Important Links
Conference Proposal
ISSN
 |
 |
DOI (A digital object identifier)
  Providing A digital object identifier by DOI How to GET DOI and Hard Copy Related |
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
 |
 |
 |
Social Media
Indexing Partner |
|||
| Copyright © 2024 - All Rights Reserved - IJSDR | |||
Facebook Twitter Instagram LinkedIn